AAO Retina SubDays Detail Up-to-the-Minute Findings

Calendar

Coding Q & A

Medicare stepping up audits of 'New Patient' rule

By RIVA LEE ASBELL

Controversies in Care

DME: When Should You Initiate Local Treatment?

CT Update

Economics of Intravitreal Medications For Neovascular AMD

Cost, VA improvement, and number of treatments factor into a balancing act.

Focus On

A New Light on Multispectral Imaging

By Stuart Michaelson, Contributing

Phototherapy for Diabetic Eye Disease

We know more than ever before about the relationships among light, hypoxia, and VEGF in diabetic retinopathy.

Subspecialty News

Eylea has positive BRVO trial; QLT begins trial for IDA treatment; Specific biomarker makes GA drug more effective; and more.

By Jerry Helzner, contributing editor

Systemic Safety Of Intravitreal VEGF Inhibitors

What concerns remain?

Ten Months to ICD-10: Will Physicians, Vendors and Payers be Ready?

Practices are training staff and physicians and meeting with system vendors and health plans as they prepare to use new codes.

The Role of Pegaptanib In the Treatment of Exudative AMD And Diabetic Retinopathy

Briefly the standard of care, pegaptanib could find a niche.

Update on Diagnosis and Treatment Of CMV Retinitis

HAART has decreased the incidence, but a definitive cure remains elusive.

Upfront

Dollars and Sense

CME - Clinical Consultations

FACULTY